Takeda Pharmaceutical Company Limited (TKDA) — Cash Flow Reinvestment Rate
Takeda Pharmaceutical Company Limited (TKDA) has a Cash Flow Reinvestment Rate of 0.63x as of December 2025, reinvesting €235.74 Billion (capex €222.37 Billion plus investments €-13.37 Billion) from operating cash flow of €373.25 Billion. Explore Takeda Pharmaceutical Company Limited capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Takeda Pharmaceutical Company Limited Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Takeda Pharmaceutical Company Limited across 9 annual periods. Also explore TKDA total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Takeda Pharmaceutical Company Limited (2017–2025)
Year-by-year capital reinvestment analysis for Takeda Pharmaceutical Company Limited. For live market cap and broader valuation context, see how much is Takeda Pharmaceutical Company Limited worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | €461.57 Billion | €1.06 Trillion | €379.62 Billion | ▼ -66.9% |
| 2024 | 1.32x | €944.59 Billion | €716.34 Billion | €480.73 Billion | ▲ +3.8% |
| 2023 | 1.27x | €1.24 Trillion | €977.16 Billion | €633.69 Billion | ▲ +981.8% |
| 2022 | 0.12x | €131.83 Billion | €1.12 Trillion | €123.25 Billion | ▼ -31.5% |
| 2021 | 0.17x | €173.21 Billion | €1.01 Trillion | €111.21 Billion | ▼ -32.1% |
| 2020 | 0.25x | €168.93 Billion | €669.75 Billion | €127.08 Billion | ▼ -34.0% |
| 2019 | 0.38x | €125.61 Billion | €328.48 Billion | €77.68 Billion | ▲ +59.0% |
| 2018 | 0.24x | €90.86 Billion | €377.85 Billion | €67.00 Billion | ▼ -8.2% |
| 2017 | 0.26x | €68.50 Billion | €261.36 Billion | €61.66 Billion | — |